ExodusPoint Capital Management’s ProKidney PROK Stock Holding History

ExodusPoint Capital Management’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$455K	Buy	254,353 +125,500	+97%	+$266K	﹤0.01%	1216
2025 Q4	$289K	Buy	128,853 +23,924	+23%	+$62.9K	﹤0.01%	1320
2025 Q3	$254K	Buy	104,929 +93,266	+800%	+$248K	﹤0.01%	1337
2025 Q2	$7K	Buy	+11,663	New	+$9.08K	﹤0.01%	1400
2023 Q2	–	Sell	-13,343	Closed	-$151K	–	2175
2023 Q1	$151K	Buy	+13,343	New	+$142K	﹤0.01%	1603
2022 Q1	–	Sell	-50,000	Closed	-$495K	–	2580
2021 Q4	$495K	Hold	50,000	–	–	0.01%	1420
2021 Q3	$490K	Hold	50,000	–	–	0.01%	1410
2021 Q2	$506K	Buy	+50,000	New	+$506K	0.01%	1397

Other funds holding PROK

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

AGP

Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ExodusPoint Capital Management's PROK Position: Q1 2026 in Review

ExodusPoint Capital Management increased its ProKidney (PROK) stake by 97% in Q1 2026, buying an estimated $266K and bringing the position to 254,353 shares worth $455K. The position accounts for ﹤0.01% of the portfolio, ranked #1216.

ExodusPoint Capital Management first reported a position in PROK in Q2 2021 and has held it in 8 quarters since. The position peaked at $506K in Q2 2021. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

ExodusPoint Capital Management held 254,353 shares of ProKidney worth $455K as of Q1 2026.
ExodusPoint Capital Management bought 125,500 ProKidney shares in Q1 2026, an estimated $266K.
ProKidney made up ﹤0.01% of ExodusPoint Capital Management's portfolio in Q1 2026, its #1216 holding.
ExodusPoint Capital Management first reported a position in ProKidney in Q2 2021 and has held it in 8 quarters since.
ExodusPoint Capital Management's ProKidney position peaked at $506K in Q2 2021.
71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.